Log In
Print
BCIQ
Print
Print this Print this
 

riboflavin ophthalmic solution (VibeX)

  Manage Alerts
Collapse Summary General Information
Company Avedro Inc.
DescriptionRiboflavin ophthalmic solution
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard Indication Ophthalmic (unspecified)
Indication DetailsTreat corneal ectasia following refractive surgery; Treat keratoconus; Treat keratoconus and corneal ectasia following refractive surgery
Regulatory Designation

U.S. - Orphan Drug (Treat keratoconus and corneal ectasia following refractive surgery);
U.S. - Priority Review (Treat keratoconus and corneal ectasia following refractive surgery)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today